Literature DB >> 8094024

A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro.

P Pook1, F Brugger, N S Hawkins, K C Clark, J C Watkins, R H Evans.   

Abstract

1. The shift in d.c. potential in dorsal roots (EC50 8.0 microM +/- 0.9 s.e. mean, n = 5) or depression of the C elevation of the compound action potential (EC50 3.0 microM +/- 0.3, n = 7) have been used to measure the depolarizing action of kainate on dorsal root C fibres of immature (3 to 5 day old) rats. Depolarization of motoneurones was measured from the shift in d.c. potential in ventral roots. 2. 6-Cyano-7-nitroquinoxaline,2-3,dione (CNQX) (pA2 5.78 +/- 0.06, n = 8) and 6-nitro-7-suplhamobenzo(f)quinoxaline-2,3-dione (NBQX) (pA2 5.75 +/- 0.04, n = 7) had similar potencies as antagonists of kainate at dorsal root fibres. The potency of NBQX as a kainate antagonist was similar also at motoneurones (pA2 5.72 +/- 0.07, n = 3). At motoneurones, NBQX was less potent as an antagonist of domoate (pA2 5.29 +/- 0.05) and more potent as an antagonist of S-alpha-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) (pA2 6.80 +/- 0.09) than as an antagonist of kainate. 3. Application of L-glutamate, quisqualate and RS-AMPA to dorsal roots produced only short lasting depolarizations but kainate concentration-effect plots were shifted to the right in the presence of these three agonists (pA2 5.08 +/- 0.08, (n = 3), 5.59 +/- 0.04, (n = 4) and 4.46 +/- 0.04 (n = 4) respectively). Slopes of dose-ratio against concentration were significantly less than one for the latter antagonism. 4. The amplitude of depolarizations induced by L-glutamate, AMPA and quisqualate were increased up to ten fold and those induced by kainate up to two fold following treatment of dorsal roots with concanavalin A. The duration of the responses was increased also by the latter treatment. Folowing 85 s applications of glutamate, quisqualate, AMPA and kainate the mean respective times (s +/- s.e.mean (n))taken for responses to decay to half the peak amplitude were increased from 63 +/- 7 (10), 86 +/- 17 (4),95 +/- 19 (4) and 135 +/- 3 (12) to 202 +/- 49 (10), 147 +/- 7 (4), 160 +/- 13 (6) and 163 +/- 10 (10). Under similar conditions the mean decay time of y-aminobutyric acid-induced responses was 145 +/- 7 (10). This was not significantly altered by concanavalin A treatment.5. Application to dorsal roots of L-aspartate at concentrations up to 5 mm (with or without concanavalin A treatment), the selective metabotropic agonist 1S,3R-trans-1-aminocyclopentane-1,3-dicarboxylate (1 mM,) and D-serine (20 pM) in the presence or absence of N-methyl-D-aspartate (NMDA,500 pM) neither depolarized the preparations nor shifted the kainate concentration-effect plot.6. It is concluded that primary afferent C fibres possess only one type of non-NMDA receptor which is activated strongly by domoate or kainate but only weakly by AMPA. This receptor is readily desensitized by glutamate, quisqualate or AMPA and it is less readily desensitized by kainate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094024      PMCID: PMC1907711          DOI: 10.1111/j.1476-5381.1993.tb13459.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  A study of the desensitization produced by acetylcholine at the motor end-plate.

Authors:  B KATZ; S THESLEFF
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

Review 2.  Glycine is a coagonist at the NMDA receptor/channel complex.

Authors:  A M Thomson
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

3.  Novel kainate derivatives: potent depolarizing actions on spinal motoneurones and dorsal root fibres in newborn rats.

Authors:  M Ishida; H Shinozaki
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

4.  Quisqualate agonists occlude kainate-induced current in cultured striatal neurons.

Authors:  F W Tse; S Weiss; B A MacVicar
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

5.  2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

Authors:  M J Sheardown; E O Nielsen; A J Hansen; P Jacobsen; T Honoré
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

6.  Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor.

Authors:  G Henderson; J W Johnson; P Ascher
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

7.  Depolarizing responses to glycine, beta-alanine and muscimol in isolated optic nerve and cuneate nucleus.

Authors:  M A Simmonds
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

8.  Effects of depressant amino acids and antagonists on an in vitro spinal cord preparation from the adult rat.

Authors:  S K Long; R H Evans; F Krijzer
Journal:  Neuropharmacology       Date:  1989-07       Impact factor: 5.250

9.  Effect of 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) on dorsal root-, NMDA-, kainate- and quisqualate-mediated depolarization of rat motoneurones in vitro.

Authors:  S K Long; D A Smith; R J Siarey; R H Evans
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

Review 10.  Experiments with kainate and quisqualate agonists and antagonists in relation to the sub-classification of 'non-NMDA' receptors.

Authors:  J C Watkins; P C Pook; D C Sunter; J Davies; T Honore
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

View more
  7 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.

Authors:  Julia C A More; Helen M Troop; Nigel P Dolman; David E Jane
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.

Authors:  Mark W Irvine; Blaise M Costa; Daniel Dlaboga; Georgia R Culley; Richard Hulse; Caroline L Scholefield; Palmi Atlason; Guangyu Fang; Richard Eaves; Richard Morley; Maria B Mayo-Martin; Mascia Amici; Zuner A Bortolotto; Lucy Donaldson; Graham L Collingridge; Elek Molnár; Daniel T Monaghan; David E Jane
Journal:  J Med Chem       Date:  2011-12-14       Impact factor: 7.446

4.  The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres.

Authors:  Julia C A More; Helen M Troop; David E Jane
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

5.  Ethanol tachyphylaxis in spinal cord motorneurons: role of metabotropic glutamate receptors.

Authors:  Hui-Fang Li; Meng-Ya Wang; Jessica Knape; Joan J Kendig
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

6.  Role of presynaptic glutamate receptors in pain transmission at the spinal cord level.

Authors:  Rita Bardoni
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363

7.  Motor Alterations Induced by Chronic 4-Aminopyridine Infusion in the Spinal Cord In vivo: Role of Glutamate and GABA Receptors.

Authors:  Rafael Lazo-Gómez; Ricardo Tapia
Journal:  Front Neurosci       Date:  2016-05-09       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.